51 related articles for article (PubMed ID: 38492358)
21. MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.
Kato M; Natarajan R
Ann N Y Acad Sci; 2015 Sep; 1353(1):72-88. PubMed ID: 25877817
[TBL] [Abstract][Full Text] [Related]
22. Identification of candidate microRNA biomarkers in diabetic nephropathy: a meta-analysis of profiling studies.
Gholaminejad A; Abdul Tehrani H; Gholami Fesharaki M
J Nephrol; 2018 Dec; 31(6):813-831. PubMed ID: 30019103
[TBL] [Abstract][Full Text] [Related]
23. TGF-Beta as a Master Regulator of Diabetic Nephropathy.
Wang L; Wang HL; Liu TT; Lan HY
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360646
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA circuits in transforming growth factor-β actions and diabetic nephropathy.
Kato M; Natarajan R
Semin Nephrol; 2012 May; 32(3):253-60. PubMed ID: 22835456
[TBL] [Abstract][Full Text] [Related]
25. Stem cell-derived and circulating exosomal microRNAs as new potential tools for diabetic nephropathy management.
Peng L; Chen Y; Shi S; Wen H
Stem Cell Res Ther; 2022 Jan; 13(1):25. PubMed ID: 35073973
[TBL] [Abstract][Full Text] [Related]
26. RNA expression signatures and posttranscriptional regulation in diabetic nephropathy.
Rudnicki M; Beckers A; Neuwirt H; Vandesompele J
Nephrol Dial Transplant; 2015 Aug; 30 Suppl 4():iv35-42. PubMed ID: 26209736
[TBL] [Abstract][Full Text] [Related]
27. MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy.
Simpson K; Wonnacott A; Fraser DJ; Bowen T
Curr Diab Rep; 2016 Mar; 16(3):35. PubMed ID: 26973290
[TBL] [Abstract][Full Text] [Related]
28. Diabetic nephropathy: The regulatory interplay between epigenetics and microRNAs.
Sankrityayan H; Kulkarni YA; Gaikwad AB
Pharmacol Res; 2019 Mar; 141():574-585. PubMed ID: 30695734
[TBL] [Abstract][Full Text] [Related]
29. miRNA signatures in diabetic retinopathy and nephropathy: delineating underlying mechanisms.
Kaur P; Kotru S; Singh S; Munshi A
J Physiol Biochem; 2022 Feb; 78(1):19-37. PubMed ID: 35098434
[TBL] [Abstract][Full Text] [Related]
30. The role of microRNAs in diabetic nephropathy.
Wu H; Kong L; Zhou S; Cui W; Xu F; Luo M; Li X; Tan Y; Miao L
J Diabetes Res; 2014; 2014():920134. PubMed ID: 25258717
[TBL] [Abstract][Full Text] [Related]
31. Perspectives on the role of PTEN in diabetic nephropathy: an update.
Khokhar M; Roy D; Modi A; Agarwal R; Yadav D; Purohit P; Sharma P
Crit Rev Clin Lab Sci; 2020 Nov; 57(7):470-483. PubMed ID: 32306805
[TBL] [Abstract][Full Text] [Related]
32. A Glimpse of the Mechanisms Related to Renal Fibrosis in Diabetic Nephropathy.
Zeng LF; Xiao Y; Sun L
Adv Exp Med Biol; 2019; 1165():49-79. PubMed ID: 31399961
[TBL] [Abstract][Full Text] [Related]
33. Role of microRNAs in kidney homeostasis and disease.
Chandrasekaran K; Karolina DS; Sepramaniam S; Armugam A; Wintour EM; Bertram JF; Jeyaseelan K
Kidney Int; 2012 Apr; 81(7):617-27. PubMed ID: 22237749
[TBL] [Abstract][Full Text] [Related]
34. The Role of MicroRNA in the Pathogenesis of Diabetic Nephropathy.
Szostak J; Gorący A; Durys D; Dec P; Modrzejewski A; Pawlik A
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047185
[TBL] [Abstract][Full Text] [Related]
35. Roles of microRNA-192 in diabetic nephropathy: the clinical applications and mechanisms of action.
Wan X; Liao J; Lai H; Zhang S; Cui J; Chen C
Front Endocrinol (Lausanne); 2023; 14():1179161. PubMed ID: 37396169
[TBL] [Abstract][Full Text] [Related]
36. The role of non-coding RNAs in diabetic nephropathy: potential applications as biomarkers for disease development and progression.
Alvarez ML; Distefano JK
Diabetes Res Clin Pract; 2013 Jan; 99(1):1-11. PubMed ID: 23102915
[TBL] [Abstract][Full Text] [Related]
37. MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy.
Zhou H; Ni WJ; Meng XM; Tang LQ
Front Cell Dev Biol; 2020; 8():618536. PubMed ID: 33569382
[TBL] [Abstract][Full Text] [Related]
38. MicroRNAs and the glomerulus.
Kato M; Park JT; Natarajan R
Exp Cell Res; 2012 May; 318(9):993-1000. PubMed ID: 22421514
[TBL] [Abstract][Full Text] [Related]
39. Epigenetics in the pathogenesis of diabetic nephropathy.
Li X; Lu L; Hou W; Huang T; Chen X; Qi J; Zhao Y; Zhu M
Acta Biochim Biophys Sin (Shanghai); 2022 Jan; 54(2):163-172. PubMed ID: 35130617
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-21: A Critical Pathogenic Factor of Diabetic Nephropathy.
Liu S; Wu W; Liao J; Tang F; Gao G; Peng J; Fu X; Zhan Y; Chen Z; Xu W; Zhao S
Front Endocrinol (Lausanne); 2022; 13():895010. PubMed ID: 35865316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
